Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-dose Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00074269
What this trial is testing

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Diego 5
Testing effectiveness (Phase 2)Study completedNCT00004169
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease

Who this might be right for
Lymphoma
Northwestern University
Not applicableEnded earlyNCT00673179
What this trial is testing

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

Who this might be right for
Osteosarcoma
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00204646
What this trial is testing

Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)

Who this might be right for
Sarcoma, Soft Tissue
University Hospital Tuebingen
Large-scale testing (Phase 3)UnknownNCT00028886
What this trial is testing

Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Commissie Voor Klinisch Toegepast Onderzoek 450
Testing effectiveness (Phase 2)Study completedNCT00472056
What this trial is testing

Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 93
Large-scale testing (Phase 3)UnknownNCT00883961
What this trial is testing

Exercise Following Autologous Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematological Disease
Charite University, Berlin, Germany 60
Testing effectiveness (Phase 2)UnknownNCT00526734
What this trial is testing

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Erasme University Hospital 100
Testing effectiveness (Phase 2)UnknownNCT00002628
What this trial is testing

Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
St. Louis University 50
Testing effectiveness (Phase 2)Ended earlyNCT01468311
What this trial is testing

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma

Who this might be right for
Hodgkin DiseaseHodgkin Lymphoma
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT00003700
What this trial is testing

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 163
Testing effectiveness (Phase 2)Study completedNCT02024009
What this trial is testing

Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2

Who this might be right for
Pancreatic Neoplasms (Locally Advanced Non-metastatic)
University of Oxford 159
Large-scale testing (Phase 3)Study completedNCT00002945
What this trial is testing

High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute 61
Large-scale testing (Phase 3)Study completedNCT03888677
What this trial is testing

Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer

Who this might be right for
Breast Cancer
Henrik Lindman 1,535
Early research (Phase 1)Active Not RecruitingNCT04231877
What this trial is testing

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+6 more
University of Washington 56
Testing effectiveness (Phase 2)Study completedNCT01562977
What this trial is testing

Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL

Who this might be right for
Aggressive LymphomaDiffuse Large B-cell LymphomaMantle Cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 82
Post-approval studies (Phase 4)Study completedNCT00336531
What this trial is testing

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
NeuroblastomaBrain TumorRetinoblastoma+2 more
Samsung Medical Center 100
Testing effectiveness (Phase 2)Looking for participantsNCT05180097
What this trial is testing

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Canadian Cancer Trials Group 84
Large-scale testing (Phase 3)Study completedNCT00006434
What this trial is testing

Tumor Lysate Pulsed-Dendritic Cell Vaccines After High-Dose Chemotherapy for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
National Center for Research Resources (NCRR)
Testing effectiveness (Phase 2)Study completedNCT00003392
What this trial is testing

High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 61
Next Page